<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
	>

<channel>
	<title>HVTNews</title>
	<atom:link href="http://hvtnews.wordpress.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://hvtnews.wordpress.com</link>
	<description>The newsletter of the HIV Vaccine Trials Network</description>
	<lastBuildDate>Wed, 21 Sep 2011 18:10:22 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.com/</generator>
<cloud domain='hvtnews.wordpress.com' port='80' path='/?rsscloud=notify' registerProcedure='' protocol='http-post' />
<image>
		<url>http://1.gravatar.com/blavatar/17913bbed08bb683fea7f87dda177c77?s=96&#038;d=http%3A%2F%2Fs2.wp.com%2Fi%2Fbuttonw-com.png</url>
		<title>HVTNews</title>
		<link>http://hvtnews.wordpress.com</link>
	</image>
	<atom:link rel="search" type="application/opensearchdescription+xml" href="http://hvtnews.wordpress.com/osd.xml" title="HVTNews" />
	<atom:link rel='hub' href='http://hvtnews.wordpress.com/?pushpress=hub'/>
		<item>
		<title>Welcome to the HVTNews</title>
		<link>http://hvtnews.wordpress.com/2011/09/16/welcome-to-the-hvtnews/</link>
		<comments>http://hvtnews.wordpress.com/2011/09/16/welcome-to-the-hvtnews/#comments</comments>
		<pubDate>Fri, 16 Sep 2011 18:06:37 +0000</pubDate>
		<dc:creator>HVTNews</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://hvtnews.wordpress.com/?p=318</guid>
		<description><![CDATA[by Jim Kublin, Executive Director, HVTN Welcome to the HVTNews. With this edition, we would like to welcome new audiences and reintroduce our newsletter. In this and future editions we will clarify why HIV vaccine research in humans provides critical momentum for the discovery and development of effective vaccines. Upcoming newsletter topics include monoclonal antibodies [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=hvtnews.wordpress.com&amp;blog=20912261&amp;post=318&amp;subd=hvtnews&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://hvtnews.wordpress.com/2011/09/16/welcome-to-the-hvtnews/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/d5595d41dab887f320cb05b20ba0b559?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">hvtnews</media:title>
		</media:content>

		<media:content url="http://hvtnews.files.wordpress.com/2011/09/globe1.jpg" medium="image">
			<media:title type="html">end</media:title>
		</media:content>
	</item>
		<item>
		<title>A Sequential Two-stage Trial Design for Evaluating Efficacy and Immune Correlates for Multiple Vaccine Regimens</title>
		<link>http://hvtnews.wordpress.com/2011/09/15/a-sequential-two-stage-trial-design-for-evaluating-efficacy-and-immune-correlates-for-multiple-vaccine-regimens/</link>
		<comments>http://hvtnews.wordpress.com/2011/09/15/a-sequential-two-stage-trial-design-for-evaluating-efficacy-and-immune-correlates-for-multiple-vaccine-regimens/#comments</comments>
		<pubDate>Thu, 15 Sep 2011 08:00:25 +0000</pubDate>
		<dc:creator>HVTNews</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://hvtnews.wordpress.com/?p=114</guid>
		<description><![CDATA[by Peter Gilbert, Doug Grove Introduction Of the 5 preventative HIV vaccine efficacy trials that have been conducted to date, 3 (Vax004, Vax003, and Step/HVTN 502) showed a vaccine efficacy (VE) near zero.1,2,3 The fourth trial, RV144, provided an estimated VE = 31%.4 The 5th trial (HVTN 503/Phambili) was halted early and did not yield [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=hvtnews.wordpress.com&amp;blog=20912261&amp;post=114&amp;subd=hvtnews&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://hvtnews.wordpress.com/2011/09/15/a-sequential-two-stage-trial-design-for-evaluating-efficacy-and-immune-correlates-for-multiple-vaccine-regimens/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/d5595d41dab887f320cb05b20ba0b559?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">hvtnews</media:title>
		</media:content>

		<media:content url="http://hvtnews.files.wordpress.com/2011/09/trial-duration.jpg?w=613" medium="image">
			<media:title type="html">trial-duration</media:title>
		</media:content>
	</item>
		<item>
		<title>Sieve Analysis of HIV Sequences in Vaccine Efficacy Trials</title>
		<link>http://hvtnews.wordpress.com/2011/09/15/sieve-analysis-of-hiv-sequences-in-vaccine-efficacy-trials/</link>
		<comments>http://hvtnews.wordpress.com/2011/09/15/sieve-analysis-of-hiv-sequences-in-vaccine-efficacy-trials/#comments</comments>
		<pubDate>Thu, 15 Sep 2011 07:00:13 +0000</pubDate>
		<dc:creator>HVTNews</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://hvtnews.wordpress.com/?p=184</guid>
		<description><![CDATA[by Peter Gilbert, Allan deCamp, Paul Edlefsen, Craig Magaret, Tomer Hertz Introduction Sieve analysis is integral to the evaluation of immune correlates of protection, as vaccine-induced immune responses (whether measurable or not) are the cause of vaccine sieve effects. (Vaccine sieve effects are vaccine-induced adaptive immune responses that may partially block HIV acquisition, and/or alter [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=hvtnews.wordpress.com&amp;blog=20912261&amp;post=184&amp;subd=hvtnews&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://hvtnews.wordpress.com/2011/09/15/sieve-analysis-of-hiv-sequences-in-vaccine-efficacy-trials/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/d5595d41dab887f320cb05b20ba0b559?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">hvtnews</media:title>
		</media:content>

		<media:content url="http://hvtnews.files.wordpress.com/2011/09/percentepitope.jpg" medium="image">
			<media:title type="html">percent epitope</media:title>
		</media:content>

		<media:content url="http://hvtnews.files.wordpress.com/2011/09/gag84.jpg" medium="image">
			<media:title type="html">gag84</media:title>
		</media:content>

		<media:content url="http://hvtnews.files.wordpress.com/2011/09/globe1.jpg" medium="image">
			<media:title type="html">end</media:title>
		</media:content>
	</item>
		<item>
		<title>Training and Mentorship Programs at the HVTN</title>
		<link>http://hvtnews.wordpress.com/2011/09/15/training-and-mentorship-programs-at-the-hvtn/</link>
		<comments>http://hvtnews.wordpress.com/2011/09/15/training-and-mentorship-programs-at-the-hvtn/#comments</comments>
		<pubDate>Thu, 15 Sep 2011 06:00:26 +0000</pubDate>
		<dc:creator>HVTNews</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://hvtnews.wordpress.com/?p=205</guid>
		<description><![CDATA[by Blythe Adamson The HVTN believes that the continued investment in research and in the next generation of researchers is crucial to the success of our ultimate goal &#8212; finding an effective preventive HIV vaccine. To that end, the Network established 3 special programs that address the unique requirements of the HIV vaccine field. The [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=hvtnews.wordpress.com&amp;blog=20912261&amp;post=205&amp;subd=hvtnews&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://hvtnews.wordpress.com/2011/09/15/training-and-mentorship-programs-at-the-hvtn/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/d5595d41dab887f320cb05b20ba0b559?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">hvtnews</media:title>
		</media:content>

		<media:content url="http://hvtnews.files.wordpress.com/2011/09/globe1.jpg" medium="image">
			<media:title type="html">end</media:title>
		</media:content>
	</item>
		<item>
		<title>Defining the Targets of HIV-specific T-cell Responses (epitope mapping)</title>
		<link>http://hvtnews.wordpress.com/2011/09/15/defining-the-targets-of-hiv-specific-t-cell-responses-epitope-mapping/</link>
		<comments>http://hvtnews.wordpress.com/2011/09/15/defining-the-targets-of-hiv-specific-t-cell-responses-epitope-mapping/#comments</comments>
		<pubDate>Thu, 15 Sep 2011 03:00:54 +0000</pubDate>
		<dc:creator>HVTNews</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://hvtnews.wordpress.com/?p=225</guid>
		<description><![CDATA[by Nicole Frahm Epitope mapping determines which regions of a given pathogen (e.g. HIV) are recognized by T cells in response to infection or vaccination. The size and makeup of these mapped regions are characterizedz by the tools used in the process, i.e. the peptides tested in the immune assay of choice. In most cases, [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=hvtnews.wordpress.com&amp;blog=20912261&amp;post=225&amp;subd=hvtnews&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://hvtnews.wordpress.com/2011/09/15/defining-the-targets-of-hiv-specific-t-cell-responses-epitope-mapping/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/d5595d41dab887f320cb05b20ba0b559?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">hvtnews</media:title>
		</media:content>

		<media:content url="http://hvtnews.files.wordpress.com/2011/09/all-responses-blue.jpg" medium="image">
			<media:title type="html">breadth of vaccine-induced T-cell response</media:title>
		</media:content>

		<media:content url="http://hvtnews.files.wordpress.com/2011/09/globe1.jpg" medium="image">
			<media:title type="html">end</media:title>
		</media:content>
	</item>
		<item>
		<title>HVTN Protocols &#8212; Enrolling or in Active Follow Up</title>
		<link>http://hvtnews.wordpress.com/2011/09/14/hvtn-protocols-enrolling-or-in-active-follow-up/</link>
		<comments>http://hvtnews.wordpress.com/2011/09/14/hvtn-protocols-enrolling-or-in-active-follow-up/#comments</comments>
		<pubDate>Wed, 14 Sep 2011 22:32:58 +0000</pubDate>
		<dc:creator>HVTNews</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://hvtnews.wordpress.com/?p=251</guid>
		<description><![CDATA[Start Date HVTN# N Sites Description Jan-09 205 Geovax Phase 1 120 Atlanta; Birmingham; Boston; New York; Iquitos; Lima; Nashville; Rochester; San Francisco; Seattle This is a phase 2a clinical trial to evaluate the safety and tolerability of a prime-boost regimen of the GeoVax DNA vaccine and modified vaccinia Ankara (MVA) vaccine, or of MVA [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=hvtnews.wordpress.com&amp;blog=20912261&amp;post=251&amp;subd=hvtnews&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://hvtnews.wordpress.com/2011/09/14/hvtn-protocols-enrolling-or-in-active-follow-up/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/d5595d41dab887f320cb05b20ba0b559?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">hvtnews</media:title>
		</media:content>
	</item>
		<item>
		<title>HVTN Annual Network Award Winners</title>
		<link>http://hvtnews.wordpress.com/2011/09/14/hvtn-annual-network-award-winners/</link>
		<comments>http://hvtnews.wordpress.com/2011/09/14/hvtn-annual-network-award-winners/#comments</comments>
		<pubDate>Wed, 14 Sep 2011 02:00:53 +0000</pubDate>
		<dc:creator>HVTNews</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://hvtnews.wordpress.com/?p=270</guid>
		<description><![CDATA[On June 3rd 2011 in Washington DC, the HVTN honored individuals who perform outstanding work at our sites. HVTN Service Award Reverend Edwin C. Sanders II Co-Chair of the Legacy Working GroupThe HVTN Service Award recognizes individuals who have creatively responded to a particular challenge arising in their HVTU work, and by which value has [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=hvtnews.wordpress.com&amp;blog=20912261&amp;post=270&amp;subd=hvtnews&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://hvtnews.wordpress.com/2011/09/14/hvtn-annual-network-award-winners/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/d5595d41dab887f320cb05b20ba0b559?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">hvtnews</media:title>
		</media:content>

		<media:content url="http://hvtnews.files.wordpress.com/2011/09/sanders.jpg" medium="image">
			<media:title type="html">Reverend Edwin C. Sanders II</media:title>
		</media:content>

		<media:content url="http://hvtnews.files.wordpress.com/2011/09/keefer.jpg" medium="image">
			<media:title type="html">Michael Keefer, MD</media:title>
		</media:content>

		<media:content url="http://hvtnews.files.wordpress.com/2011/09/wagner.jpg" medium="image">
			<media:title type="html">Theresa Wagner</media:title>
		</media:content>

		<media:content url="http://hvtnews.files.wordpress.com/2011/09/miko.jpg" medium="image">
			<media:title type="html">Miko Robertson</media:title>
		</media:content>
	</item>
		<item>
		<title>HVTN 505: Expansion in Response to an Evolving Field</title>
		<link>http://hvtnews.wordpress.com/2011/09/13/hvtn-505-expansion-in-response-to-an-evolving-field/</link>
		<comments>http://hvtnews.wordpress.com/2011/09/13/hvtn-505-expansion-in-response-to-an-evolving-field/#comments</comments>
		<pubDate>Tue, 13 Sep 2011 18:04:40 +0000</pubDate>
		<dc:creator>HVTNews</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://hvtnews.wordpress.com/?p=316</guid>
		<description><![CDATA[by Shelly Karuna, Carter Bentley HVTN 505 is a study of an HIV vaccine regimen developed by the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). In June 2009, the study began enrolling 1350 men and transgender women who have sex with men. The [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=hvtnews.wordpress.com&amp;blog=20912261&amp;post=316&amp;subd=hvtnews&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://hvtnews.wordpress.com/2011/09/13/hvtn-505-expansion-in-response-to-an-evolving-field/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/d5595d41dab887f320cb05b20ba0b559?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">hvtnews</media:title>
		</media:content>

		<media:content url="http://hvtnews.files.wordpress.com/2011/09/nashvillestaff.jpg" medium="image">
			<media:title type="html">nashville staff</media:title>
		</media:content>

		<media:content url="http://hvtnews.files.wordpress.com/2011/09/atlantastaff.jpg" medium="image">
			<media:title type="html">Atlanta staff</media:title>
		</media:content>

		<media:content url="http://hvtnews.files.wordpress.com/2011/09/globe1.jpg" medium="image">
			<media:title type="html">end</media:title>
		</media:content>
	</item>
		<item>
		<title>Exploring Barriers and Facilitators to Participation of Male-To-Female Transgender Persons in HIV Vaccine Clinical Trials</title>
		<link>http://hvtnews.wordpress.com/2011/09/02/exploring-barriers-and-facilitators-to-participation-of-male-to-female-transgender-persons-in-hiv-vaccine-clinical-trials/</link>
		<comments>http://hvtnews.wordpress.com/2011/09/02/exploring-barriers-and-facilitators-to-participation-of-male-to-female-transgender-persons-in-hiv-vaccine-clinical-trials/#comments</comments>
		<pubDate>Fri, 02 Sep 2011 00:02:54 +0000</pubDate>
		<dc:creator>HVTNews</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://hvtnews.wordpress.com/?p=359</guid>
		<description><![CDATA[by Michele Peake Andrasik Transgender is a term used to describe a range of individuals with atypical gender characteristics, or with gender identities discordant from their biological sex. Male-to-female (MTF) transgender communities experience high HIV prevalence and African American race has been found to be the strongest risk factor for HIV infection among MTF transgender [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=hvtnews.wordpress.com&amp;blog=20912261&amp;post=359&amp;subd=hvtnews&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://hvtnews.wordpress.com/2011/09/02/exploring-barriers-and-facilitators-to-participation-of-male-to-female-transgender-persons-in-hiv-vaccine-clinical-trials/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/d5595d41dab887f320cb05b20ba0b559?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">hvtnews</media:title>
		</media:content>

		<media:content url="http://hvtnews.files.wordpress.com/2011/09/aamina.jpg" medium="image">
			<media:title type="html">aamina</media:title>
		</media:content>

		<media:content url="http://hvtnews.files.wordpress.com/2011/09/globe1.jpg" medium="image">
			<media:title type="html">end</media:title>
		</media:content>

		<media:content url="http://hvtnews.files.wordpress.com/2011/09/focusgroup.jpg" medium="image">
			<media:title type="html">focus group demographics</media:title>
		</media:content>
	</item>
		<item>
		<title>Recent HVTN Publications September 2010 – September 2011</title>
		<link>http://hvtnews.wordpress.com/2011/09/01/recent-hvtn-publications/</link>
		<comments>http://hvtnews.wordpress.com/2011/09/01/recent-hvtn-publications/#comments</comments>
		<pubDate>Thu, 01 Sep 2011 00:12:15 +0000</pubDate>
		<dc:creator>HVTNews</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://hvtnews.wordpress.com/?p=162</guid>
		<description><![CDATA[&#160; See:   &#62; Manuscripts     &#62; Abstracts Manuscripts • Li F, Finnefrock AC, Dubey SA, Korber BT, Szinger J, Cole S, McElrath MJ, Shiver JW, Casimiro DR, Corey L, Self SG. Mapping HIV-1 Vaccine Induced T-Cell Responses: Bias towards Less-Conserved Regions and Potential Impact on Vaccine Efficacy in the Step Study. PLoS One. [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=hvtnews.wordpress.com&amp;blog=20912261&amp;post=162&amp;subd=hvtnews&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://hvtnews.wordpress.com/2011/09/01/recent-hvtn-publications/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/d5595d41dab887f320cb05b20ba0b559?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">hvtnews</media:title>
		</media:content>
	</item>
	</channel>
</rss>
